PT TOMORROW: NL East—Espinosa making the case for larger role
May 18 2015
If there has been a silver lining to the injury suffered by Anthony Rendon (2B/3B, WAS), it has been the surprising play from Danny Espinosa (2B/SS/3B, WAS). He has done a fine job whenever called upon this season.
It’s a small sample size of 102 AB, but Espinosa has shined. He has been able to boost his ct% to a career high of 75% (12% higher than 2014) while maintaining his power (149 PX). The 28-year-old has also drawn walks at a higher rate than ever before (2015: 12% bb%; career 7% bb%). These gains have resulted into a rather robust .275/.373/.490 slash line with 5 HR. His xBA, xPX and HctX support his current surface stats. After struggling against right-handed pitching for his entire career (.656 OPS vs....
Almost!
You’re just a few clicks away from accessing this feature and hundreds more throughout the year that have a singular goal in mind: Winning your league. Subscribe to BaseballHQ.com here!
Already a subscriber? Sign in here
More From PT Tomorrow
With teams still putting rosters together, each of the NL West teams (even the Dodgers), has some work to do. What are next steps each team might take?
Jan 29 2026 3:06am
Jan 29 2026 3:06am
What does the acquisition of Luisangel Acuña mean for the outfield picture in Chicago? Plus, a look at DET SS options, the catcher situation in KC, and the CLE and MIN rotations.
Jan 26 2026 3:03am
Jan 26 2026 3:03am
Ben Williamson is currently the projected third baseman for the Mariners, but a shakeup may be needed.
Jan 20 2026 3:01am
Jan 20 2026 3:01am
Chicago signed Bregman to a 5-year/$175 million deal, how does it impact their roster?
Jan 15 2026 3:09am
Jan 15 2026 3:09am
Coby Mayo (pictured) and Ryan Mountcastle have been squeezed from regular reps in BAL, while Triston Casas is in a similar spot in BOS; plus, more offseason fallout from the AL East.
Jan 13 2026 3:01am
Jan 13 2026 3:01am
